Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2001
01/30/2001US6180354 Metal chelate containing compositions for use in chemiluminescent assays
01/30/2001US6180346 Electropolymerizable film, and method of making and use thereof
01/30/2001US6180340 Extended dynamic range assays
01/30/2001US6180336 Labelling and selection of molecules
01/30/2001US6180335 Monitoring the amount of microorganism impurity in sample; mixing sample with buffer, filtering sample through filter paper, incubate sample in antibody abosorbent layer, measure amount of bound label in antibody layer
01/30/2001US6180334 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of ‘aggrecanase’ in cell culture systems
01/30/2001US6180333 Classification of tumors; obtaining tumor tissue, evaluating preferential protein amounts, comparing to control levels, classifying tumor pathology
01/30/2001US6180288 Gel sensors and method of use thereof
01/30/2001US6180135 Comining diacetylene lipid monomers, ligands selected from of proteins, antibodies, peptides, carbohydrates, nucleic acids, and solvent; evaporating solvent; adding aqueous solution; agitating, cooling to produce liposomes; polymerization
01/30/2001US6180109 Nucleotide and polypeptide sequences of pestivirus strains
01/30/2001US6180104 Can be used such as nucleotide probes, combining with foreign dna sequences to produce novel t-cell receptors, which can be used in an analogous manner as antibodies, or constructs can be provided which provide for extrachromosomal elements
01/30/2001US6180084 Contacting purified ngr receptor with one or more molecules and determining specific binding of molecule to ngr receptor, where presence of specific binding identifies molecule as tumor homing molecule that homes to angiogenic vasculature
01/30/2001US6180063 Test strip package with a plurality of test strips, each of which has a test field capable of being evaluated by means of an optical or electrical current mechanism of a measuring device; blood sugar testing for diabetes
01/30/2001US6179979 Electrochemical cell
01/30/2001US6178831 Composite wastewater sampler
01/30/2001US6178815 Method to improve the quality of a formation fluid sample
01/30/2001US6178812 Methods for measuring the sorbate content of substrates
01/30/2001US6178811 Quasi-static viscometer
01/30/2001US6178810 Crude oil measurement system and method
01/30/2001CA2177604C Labelling of nucleic acid analogue-peptide chimerae
01/30/2001CA2162532C Gemstone registration system
01/30/2001CA2101942C Technetium-99m labeled polypeptides for imaging
01/30/2001CA2095022C Compositions and methods for identifying a solution
01/30/2001CA2079664C Methods for locating oil or gas deposits employing earth surface temperatures
01/30/2001CA2053268C Bacteriochlorophyll-a derivatives useful in photodynamic therapy
01/30/2001CA2030304C Incubation device for microtiter plates
01/29/2001CA2314726A1 Co gas sensor
01/27/2001CA2314447A1 Graphical viewer for biomolecular sequence data
01/25/2001WO2001006496A1 Inorganic permeation layer for micro-electric device
01/25/2001WO2001006263A1 Clinical control materials for bone resorptive markers
01/25/2001WO2001006262A1 Diagnostics and therapeutics for macular degeneration
01/25/2001WO2001006261A2 Screening for therapeutic agents being scap antagonists
01/25/2001WO2001006260A1 Detection of biomolecules by sensitizer-linked substrates
01/25/2001WO2001006259A1 A method for identifying pre-neoplastic and/or neoplastic states in mammals
01/25/2001WO2001006258A1 Method and kit for immuno-detecting bacteria in blood and tissues
01/25/2001WO2001006257A1 Metal nanoshells for biosensing applications
01/25/2001WO2001006256A1 Polymer for binding amine containing ligands and uses thereof
01/25/2001WO2001006254A1 Cell enrichment
01/25/2001WO2001006253A2 Detection system based on an analyte reactive particle
01/25/2001WO2001006252A2 Prediction of hepatic failure following hepatitis c
01/25/2001WO2001006251A2 Process for the quantitative determination of alkaloids such as cocaine in a solid sample and reagent for use in such process
01/25/2001WO2001006250A2 Thermo-chemical sensors and uses thereof
01/25/2001WO2001006248A2 Biosensors for monitoring air conditioning and refrigeration processes
01/25/2001WO2001006246A1 Sensor assembly for detecting proportions of gas in gas streams containing particles
01/25/2001WO2001006245A1 Polymeric compositions and sensor devices
01/25/2001WO2001006244A2 General signaling protocols for chemical receptors in immobilized matrices
01/25/2001WO2001006243A1 Method for measuring substance and measurement reagent to be used in the method
01/25/2001WO2001006241A1 Arrangement for measuring properties of a moving paper web
01/25/2001WO2001006239A2 Method and apparatus for the delivery of samples to a chemical sensor array
01/25/2001WO2001006229A2 Analytical sampling device
01/25/2001WO2001006227A2 Production and use of luminescent microparticles and nanoparticles
01/25/2001WO2001006225A1 Test for brake fluid age and condition
01/25/2001WO2001006016A2 Amplification of nucleic acids with electronic detection
01/25/2001WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6
01/25/2001WO2001006013A1 Methods for determining the specificity and sensitivity of oligonucleotides for hybridization
01/25/2001WO2001006007A2 Method for the identification of a receptor
01/25/2001WO2001006005A2 Diagnostic method comprising wt1 sequences
01/25/2001WO2001006002A1 Biochemical sensor system with increased sensitivity by molecular amplification of the signal
01/25/2001WO2001005999A1 Assay member and method for its manufacture
01/25/2001WO2001005993A1 Cellular absorption of dna
01/25/2001WO2001005983A1 Dsp-11 dual-specificity map kinase phosphatase
01/25/2001WO2001005972A1 Compositions and methods for the treatment of immune related diseases
01/25/2001WO2001005970A2 Gtp-binding protein associated factors
01/25/2001WO2001005969A2 Electron transfer proteins
01/25/2001WO2001005968A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor
01/25/2001WO2001005967A1 Splice variants of cd40-receptor
01/25/2001WO2001005948A1 Assay of the activation state of platelets
01/25/2001WO2001005947A1 Melanin-concentrating hormone receptor
01/25/2001WO2001005944A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
01/25/2001WO2001005837A1 Method for assaying compounds affecting smooth muscle contractile state
01/25/2001WO2001005833A1 Odorant receptors
01/25/2001WO2001005831A1 Modulation of human sodium channels in dorsal root ganglia
01/25/2001WO2001005828A1 Novel human calcium sensitive potassium channel subunits
01/25/2001WO2001005824A2 Synthetic peptides immunoreactive with hepatitis a virus antibodies
01/25/2001WO2001005514A1 Travelling wave dielectrophoretic apparatus and method
01/25/2001WO2001005509A1 A low binding liquid retaining and filtering device
01/25/2001WO2001005480A2 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor
01/25/2001WO2001005427A1 Psca: prostate stem cell antigen and uses thereof
01/25/2001WO2001005426A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
01/25/2001WO2001005422A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease
01/25/2001WO2001005401A1 Melanocortin receptor-3 ligands to treat sexual dysfunction
01/25/2001WO2000073413A3 Apparatus and method for cell disruption
01/25/2001WO2000071566A3 Novel organic anion transport proteins
01/25/2001WO2000068693A3 METHODS BASED ON LOCALIZATION OF Hsp90 TO THE CENTROSOME
01/25/2001WO2000067739A3 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects
01/25/2001WO2000065355B1 Methods and compositions for determining latent viral load
01/25/2001WO2000064930A3 Tribonectins
01/25/2001WO2000063357A3 Methods and compositions for modulating ciliary neurotrophic factor activity
01/25/2001WO2000062070A3 Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker
01/25/2001WO2000062065B1 Complex formed by n-linked glycoproteins (siblings) and factor h
01/25/2001WO2000060080A3 Molecules of the immune system
01/25/2001WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
01/25/2001WO2000058472A3 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same
01/25/2001WO2000057837A3 Compositions and methods for effecting the levels of cholesterol
01/25/2001WO2000054580A3 Leukotriene b4 receptor transgenic mammals
01/25/2001WO2000054050A3 Method for detecting conditions by analysis of aqueous condensate from respiratory gases
01/25/2001WO2000047721A3 Methods of inducing insulin positive progenitor cells
01/25/2001DE19947635A1 Fibrous structure, e.g. paper, containing active agents for liquid treatment, useful e.g. in food processing or in softening or purifying water
01/25/2001DE19934881A1 Einrichtung zur Messung der Feuchtigkeit von Erntegut Means for measuring the moisture of the crop
01/25/2001DE19934547A1 Testing synthetic materials involves supporting specimen along peripheral surface enclosing bending aperture in support, exerting single force on opposite side of specimen from holder by ram